| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/16/2006 | WO2005016884A9 Cyclopropyl derivatives as nk3 receptor antagonists |
| 03/16/2006 | WO2005016235A3 Combined use of impdh inhibitors with toll-like receptor agonists |
| 03/16/2006 | WO2004110419A8 Agonist agents and medicinal compositions |
| 03/16/2006 | WO2004033663A3 Carbohydrate-based synthetic vaccines for hiv |
| 03/16/2006 | US20060059576 Treatment of neurodegenerative conditions with nimesulide |
| 03/16/2006 | US20060058570 Radioactive member and method of making |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058552 Solid preferably with an aspect ratio of 1 to 4 and a solubility in water at room temperature of at least 425 mg/ml. |
| 03/16/2006 | US20060058541 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 03/16/2006 | US20060058535 Manufacture of ascorbic acid esters |
| 03/16/2006 | US20060058533 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/16/2006 | US20060058531 red pigments has superior dispersibility in binder, non-flocculated, produce a desired hue; contains p-benzenedicarboxylic acid group; printing inks, paints, colorants for various plastics, toner |
| 03/16/2006 | US20060058525 Synthesis of 2,4-pyrimidinediamine compounds |
| 03/16/2006 | US20060058523 Quinazoline compounds |
| 03/16/2006 | US20060058513 Oxime conjugates and methods for their formation and use |
| 03/16/2006 | US20060058508 Novel functional peptide nucleic acid and process for producing the same |
| 03/16/2006 | US20060058399 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 03/16/2006 | US20060058398 Medicinal compositions containing vitamin k's as nerve growth factor potentiator and utilization thereof |
| 03/16/2006 | US20060058396 Amide compounds for the potentiation of cholinergic activity |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/16/2006 | US20060058394 Medicine of post-traumatic stress disorder |
| 03/16/2006 | US20060058393 Peroxisome proliferator activated receptor moderators; dyslipidemia; anticholesterol agents ; antidiabetic agents; hypotensive agents; antiischemic agents |
| 03/16/2006 | US20060058392 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 03/16/2006 | US20060058391 Calcium receptor antagonist; (E)-3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-acrylic acid hydrochloride; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, arthritis, Paget's disease, humoral hypercalcemia, osteoporosis |
| 03/16/2006 | US20060058390 D-methionine formulation with improved biopharmaceutical properties |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058388 Methods for treating ocular diseases via introxide and or polyhydroxy acid containing compounds |
| 03/16/2006 | US20060058387 Composition and method for treating skin conditions |
| 03/16/2006 | US20060058386 Painless injectable compositons containing salts of 2-arylpropionic acids |
| 03/16/2006 | US20060058385 Combination of antidiabetic drugs |
| 03/16/2006 | US20060058384 Treatment of IGA nephropathy with omega-3 fatty acids |
| 03/16/2006 | US20060058383 Propyl 3-bromo-2-oxopropionate and derivatives as novel anticancer agents |
| 03/16/2006 | US20060058382 Peroxisome proliferator activated receptors; dyslipidema |
| 03/16/2006 | US20060058381 Pharmaceutical formulation comprising (r)-bicalitamide |
| 03/16/2006 | US20060058380 Novel aminobenzophenone compounds |
| 03/16/2006 | US20060058379 Connexin 26 inhibitor and cancer metastasis inhibitors |
| 03/16/2006 | US20060058378 reducing neovascularization by administering mixture of acid such as citric acid, ascorbic acid |
| 03/16/2006 | US20060058377 7-oxabicyclo(2,2,1)heptane derivatives; hypoxia-inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF) inhibitor; anticarcinogenic, antihypoxic agent; heart disease, stroke, macular degeneration, diabetic retinopathy, arthritis |
| 03/16/2006 | US20060058376 Composition having autonomic nerve modulating activity and method of use thereof |
| 03/16/2006 | US20060058375 Method of treating dry eye disorders and uveitis |
| 03/16/2006 | US20060058374 Urotensin II receptor agents |
| 03/16/2006 | US20060058373 Novel substituted sulfamate anticonvulsant derivatives |
| 03/16/2006 | US20060058372 N-Benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarboxamide derivatives and pharmaceutical compositions comprising them |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058370 Methods for producing cyclic benzamidine derivatives |
| 03/16/2006 | US20060058369 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors |
| 03/16/2006 | US20060058368 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 03/16/2006 | US20060058367 Synthesis of amines and intermediates for the synthesis thereof |
| 03/16/2006 | US20060058366 Jnk inhibitor |
| 03/16/2006 | US20060058365 Compositions and methods for treatment of colitis |
| 03/16/2006 | US20060058364 Treatment of dependence and dependence related withdrawal symptoms |
| 03/16/2006 | US20060058363 Nitric oxide releasing selective cyclooxygenase-2 inhibitors |
| 03/16/2006 | US20060058362 7-Amido-isoindolyl compounds and methods of their use |
| 03/16/2006 | US20060058361 Therapeutic diphenyl ether ligands |
| 03/16/2006 | US20060058360 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 03/16/2006 | US20060058358 Pharmaceutical compositions for the treatment of hyper-proliferative disorders |
| 03/16/2006 | US20060058357 Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke |
| 03/16/2006 | US20060058356 Indolylmaleimide derivatives |
| 03/16/2006 | US20060058355 Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker |
| 03/16/2006 | US20060058354 Conjugated aromatic compounds with a pyridine substituent |
| 03/16/2006 | US20060058353 Benzofuran derivatives, process for their preparation and intermediates thereof |
| 03/16/2006 | US20060058352 Piperidine amine compounds and their use |
| 03/16/2006 | US20060058351 Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors |
| 03/16/2006 | US20060058347 high purity amorphous quinapril hydrochloride can be obtained specially free of diketopiperazine impurity |
| 03/16/2006 | US20060058346 Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 03/16/2006 | US20060058345 Use of papaverine-like vasodilator and pharmaceutical composition |
| 03/16/2006 | US20060058344 Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 03/16/2006 | US20060058342 For therapy and prophylaxis of hypokalemia, hypertension, congestive heart failure, renal failure, in particular, chronic renal failure, restenosis, atherosclerosis, syndrome X, obesity, nephropathy, post-myocardial infarction, coronary heart diseases, increased formation of collagen, fibrosis |
| 03/16/2006 | US20060058341 Inhibitors of ATP-protein kinase; 7-(3-chloro-4-fluoro-phenylamino)-2-(4-pyrrolidin-1-ylmethyl-phenylamino)-thiazolo[4,5-b]pyridine-6-carbonitrile |
| 03/16/2006 | US20060058340 Pyrrolo[2,3-b]pyridine derivatives; benzyl-[5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-pyridin-2-yl]-amine; receptor protein tyrosine kinase modulators; diseases related to improperly regulated kinase signal transduction like proliferative, inflammatory and metabolic disorders |
| 03/16/2006 | US20060058339 Compounds modulating c-kit activity and uses therefor |
| 03/16/2006 | US20060058338 [1,7]naphthyridines as pde4 inhibitors |
| 03/16/2006 | US20060058337 4-{[(6R)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 3-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 4-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; cytokine expression |
| 03/16/2006 | US20060058336 Pharmaceutical composition for treatment of drug dependence |
| 03/16/2006 | US20060058335 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| 03/16/2006 | US20060058334 provides substantially pure desloratadine having an HPLC purity greater than 99.5% and having an absorbance less than 0.15 Au at 420 nm for a 5% w/v solution in methanol; acidic hydrolysis; 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; allergic rhinitis |
| 03/16/2006 | US20060058333 Analgesic compositions containing buprenorphine |
| 03/16/2006 | US20060058332 sublingual administration of N-cyclopropylmethyl-7 alpha -[1-(S)-hydroxy-1,2,2-trimethylpropyl]6,14-endoethano-6,7,8,14-tetrahydro-nororipavine, in combination with naloxone, naltrexone or nalmefene; synergistic mixtures for the treatment of pain in humans or animals |
| 03/16/2006 | US20060058331 Abuse resistant opioid dosage form |
| 03/16/2006 | US20060058330 Rylene derivatives and their use as dyes |
| 03/16/2006 | US20060058329 Pyrazole inhibitors of the transforming growth factor |
| 03/16/2006 | US20060058328 Use of N-aryl diazaspiracyclic compounds in the treatment of addiction |
| 03/16/2006 | US20060058327 Mitotic kinesin inhibitors |
| 03/16/2006 | US20060058326 Pyrimidines, methods for the production thereof, and use thereof |
| 03/16/2006 | US20060058325 Therapeutic quniazoline derivatives |
| 03/16/2006 | US20060058324 4-Amino-5-phenyl-7-cyclohexyl-pyrrolo 2,3-d pyrimidine derivatives |
| 03/16/2006 | US20060058323 New 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 03/16/2006 | US20060058322 Method of wound healing using A2B adenosine receptor antagonists |
| 03/16/2006 | US20060058321 Enzyme inhibitors for kinases and antitumor agents with bicyclic or tricyclic compounds with thiophene ring |
| 03/16/2006 | US20060058320 [1,2,4] Triazolo[1,5-c]pyrimidine derivatives |
| 03/16/2006 | US20060058319 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 03/16/2006 | US20060058318 Prodrugs of an ERK protein kinase inhibitor |
| 03/16/2006 | US20060058317 Oxazolidinone derivatives as antibacterial |
| 03/16/2006 | US20060058316 Side effect reduction; asthma; antiinflammatory agent; cognition enhancers; 2-{3'-[3-[(Cyclopropylamino)carbonyl]-4-oxo-1,8-naphthyridin-1(4H)-yl]-1-biphenyl-4-yl}cyclopropanecarboxylic acid |
| 03/16/2006 | US20060058315 2-Oxo-ethanesulfonamide derivates |
| 03/16/2006 | US20060058314 Oxazolidinone derivatives and their use as antibacterial agents |
| 03/16/2006 | US20060058313 Treatment of mesothelioma |